Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update studying the immunomodulatory effects of rapamycin on pregnancy rate in patients with recurrent implantation failure. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rapamycin (sirolimus)

Snippet

Sponsor: Mehdi Yousefi | Conditions: Recurrent Implantation Failure | Phase 2 | Status: COMPLETED